bisindolylmaleimide i has been researched along with Arthritis, Rheumatoid in 1 studies
bisindolylmaleimide I: a bis(indolyl)maleimide
Arthritis, Rheumatoid: A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mino, T | 1 |
| Sugiyama, E | 1 |
| Taki, H | 1 |
| Kuroda, A | 1 |
| Yamashita, N | 1 |
| Maruyama, M | 1 |
| Kobayashi, M | 1 |
1 other study available for bisindolylmaleimide i and Arthritis, Rheumatoid
| Article | Year |
|---|---|
Interleukin-1alpha and tumor necrosis factor alpha synergistically stimulate prostaglandin E2-dependent production of interleukin-11 in rheumatoid synovial fibroblasts.
Topics: Arthritis, Rheumatoid; Carcinogens; Cells, Cultured; Dinoprostone; Drug Synergism; Enzyme Inhibitors | 1998 |